News

print


Product News and Articles

51 - 60 of 168 Articles Previous 6 7 8 Next Next

05/02/2013

PLOS ONE Study: Droplet Digital™ PCR Works for GMO Quantification

A new study demonstrates that Droplet Digital PCR (ddPCR™) technology is suitable for routine analysis of genetically modified organisms (GMOs) in food, feed, and seeds. The ddPCR assay is more accurate and reliable than real-time quantitative PCR (qPCR) for quantifying GMOs, especially at low levels.
More »

04/16/2013

Bio-Rad’s New ddPCR™ Library Quantification Kit Optimizes Performance of Illumina NGS Platforms

Bio-Rad’s new ddPCR library quantification kit for Illumina TruSeq sample preparation kits enables QX100™ Droplet Digital™ PCR system users to precisely and directly measure amplifiable library concentrations for next-generation sequencing.
More »

04/09/2013

Droplet Digital™ PCR Improves Detection Sensitivity of Telomerase Activity Assay

Droplet Digital PCR (ddPCR™) technology dramatically enhances current telomerase activity assays, with important implications for the early detection of cancer and the rapid evaluation of cancer therapeutics.
More »

03/12/2013

Bio-Rad Receives Frost & Sullivan 2012 North American Laboratory Researchers’ Choice: Future Market Leader of Digital PCR Technology Award

The QX100™ Droplet Digital™ PCR system was cited as the future market leader in digital PCR systems for its precision, simple workflow, and affordability. More than half of the researchers surveyed plan to buy a QX100 system in the next year
More »

03/09/2013

Bio-Rad Introduces New Bio-Plex Pro™ RBM Kidney Toxicity Panels

Bio-Plex Pro RBM human, rat, and canine kidney toxicity panels, developed in partnership with Myriad RBM, Inc., enable earlier quantitation of FDA-approved markers of acute and chronic kidney injury in clinical and preclinical settings with unprecedented sensitivity.
More »

02/20/2013

Bio-Rad Has Acquired AbD Serotec

Bio-Rad has completed the acquisition of AbD Serotec, a leading antibody manufacturer offering over 15,000 antibodies, kits, and accessories. This acquisition will accelerate future antibody development and enhance product offerings in diagnostics and life science research.
More »

02/07/2013

Bio-Rad Science Ambassador Program Provides Students Memorable Experience

As part of the recently-launched Bio-Rad Science Ambassador Program, students in the sixth and seventh grade at Jefferson Middle School conducted the Genes in a Bottle™ experiment under the guidance of Science Ambassador, Dr. Lisa Eccles.
More »

01/28/2013

Bio-Rad’s New Workflow Enables Highly Sensitive Evaluation of Antibodies Used to Measure HCP Impurities in Biotherapeutics

Bio-Rad will present a new and improved workflow for the evaluation of antibodies used to measure residual host cell protein impurities in biotherapeutics at the Well Characterized Biotechnology Pharmaceutical Symposium in Washington, D.C. January 29–31.
More »

01/04/2013

Digital PCR Pioneer Chooses Bio-Rad's QX100™ Droplet Digital™ PCR System to Develop Leukemia Test

Professor Alec Morley (Flinders University, Australia), a pioneer in digital PCR, has chosen Bio-Rad Laboratories’ QX100 Droplet Digital PCR system to develop a diagnostic test for chronic myeloid leukemia (CML). Monoquant, the company started by Morley to develop this technology, is seeking FDA approval for its new test.
More »

12/15/2012

Bio-Rad Showcases S3™ Cell Sorter at American Society for Cell Biology

Bio-Rad’s new S3 cell sorter will be shown at the American Society for Cell Biology (ASCB) Annual Meeting in San Francisco, December 15–19. The S3 cell sorter is an automated, easy-to-use, benchtop cell sorter equipped with one or two lasers, forward and side scatter detectors, and up to four fluorescent detectors.
More »

Get Help
Sign Up for Bio-Rad Updates!
Enter your email address below to receive your choice of the latest news, promotions, and more.